GLP - 1

This study is checking if the weight-loss drug tirzepatide causes older adults to lose too much muscle along with fat, which could lead to weakness. Researchers will give 20 obese adults over age 50 tirzepatide for six months and measure their muscle mass, strength, and walking a…

This study is observing whether adding a GLP-1 medication (like Wegovy/Ozempic) to a therapy program works better for people with severe obesity and binge eating disorder than therapy alone. It will follow 80 adults in Norway for a year, tracking their weight, eating disorder sym…

This study aims to find the best weight loss medication for people with bipolar disorder by first identifying their specific eating patterns, like 'emotional hunger' or 'hungry gut.' Researchers will match 100 participants to one of three FDA-approved weight loss drugs or a no-me…

This study is testing whether a new nutritional supplement can help fill nutrient gaps and improve gut health for people taking GLP-1 medications like Ozempic and Wegovy. Researchers will enroll 120 generally healthy adults in the US who are on a stable dose of these drugs. They …

This study aims to understand how newer weight-loss medications affect not just body weight, but also people's diets, eating behaviors, and overall metabolism. It will follow 100 adults with overweight or obesity for one year while they take prescribed GLP-1 or GIP/GLP-1 medicati…

This study is testing whether a dietary supplement made from plant extracts can help people manage their weight. Researchers want to see if the supplement affects gut hormones that control appetite and feelings of fullness. For 12 weeks, 40 adults with overweight or obesity will …

This study aims to understand how GLP-1RA weight loss medications affect muscle mass and bone strength in women aged 35-60. Researchers will track 50 women newly prescribed these drugs to see if their natural estrogen levels influence these changes. The goal is to gather knowledg…

This study aims to understand if a popular weight-loss medication (semaglutide) affects bone strength in teens and young adults with obesity. Researchers will follow 120 participants for two years, comparing those taking the medication to those managing weight through lifestyle c…

This study investigates whether GLP-1 and GIP agonist medications (used for diabetes and weight loss) affect how well patients' bowels are cleaned before a colonoscopy. Researchers will compare people who continue taking their usual dose before the procedure versus those who skip…